Science Explorer Back to mapMap
Discussion
Topic · Hematology

Multiple Myeloma Research and Treatments

Multiple Myeloma Research and Treatments is a research topic within Hematology. Science Explorer counts 33k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, staging, treatment, and molecular classification of multiple myeloma. It covers topics such as the International Myeloma Working Group criteria, novel therapies including proteasome inhibitors and immunomodulatory drugs, autologous transplantation, genomic abnormalities, and the role of the bone marrow microenvironment in disease progression.

  • International Myeloma Working Group
  • Diagnosis Criteria
  • Staging System
  • Novel Therapies
  • Autologous Transplantation
  • Genomic Abnormalities
  • Proteasome Inhibitors
  • Immunomodulatory Drugs
  • Minimal Residual Disease
  • Bone Marrow Microenvironment
Research works
33k
fractional, since 1950
In the world top 10%
3.5k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+22%
the tick is no change
Largest producer
United States
43% of the 10 largest, 2022-now
Multiple Myeloma Research and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Multiple Myeloma Research and Treatments research?

By volume, the United States and China publish the most (2.7k and 1.3k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.7k works
  2. 2 China 1.3k works
  3. 3 Italy 377 works
  4. 4 Germany 331 works
  5. 5 India 319 works
  6. 6 Japan 299 works
  7. 7 Spain 291 works
  8. 8 United Kingdom 283 works
  9. 9 France 271 works
  10. 10 Brazil 169 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 43.3%China: 19.8%Italy: 5.9%Germany: 5.2%6 others listed: 25.7%43%largest
United States2,741 · 43.3%China1,257 · 19.8%Italy377 · 5.9%Germany331 · 5.2%6 others listed1,631 · 25.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Multiple Myeloma Research and Treatments research?

By volume in 2022-now, Harvard University publishes the most Multiple Myeloma Research and Treatments research, followed by Mayo Clinic and The University of Texas MD Anderson Cancer Center.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 147 works
  2. 2 Mayo ClinicUnited States 146 works
  3. 3 The University of Texas MD Anderson Cancer CenterUnited States 83 works
  4. 4 Johnson & Johnson (United States)United States 72 works
  5. 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 71 works
  6. 6 Memorial Sloan Kettering Cancer CenterUnited States 67 works
  7. 7 National and Kapodistrian University of AthensGreece 58 works
  8. 8 Mount Sinai Health SystemUnited States 52 works
  9. 9 Sun Yat-sen UniversityChina 52 works
  10. 10 Cleveland ClinicUnited States 52 works

Who are the leading researchers in Multiple Myeloma Research and Treatments?

The most-cited researchers publishing on Multiple Myeloma Research and Treatments include Ahmedin Jemal, Stacey L. Gabriel and Guido Kroemer.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Stacey L. Gabriel United States 402k citations
  3. 3 Guido Kroemer France 386k citations
  4. 4 Gad A. Getz United States 364k citations
  5. 5 Elaine R. Mardis United States 346k citations
  6. 6 Hermann Brenner Germany 343k citations
  7. 7 Cyrus Cooper United Kingdom 342k citations
  8. 8 Jun Wang China 340k citations
  9. 9 Giuseppe Remuzzi Italy 328k citations
  10. 10 Todd R. Golub United States 283k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Multiple Myeloma Research and Treatments?

The most cited paper in Multiple Myeloma Research and Treatments is "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma" (S. Vincent Rajkumar et al., 2014), with 5,031 citations. Next come "Selective inhibition of BET bromodomains" (4,363) and "A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera" (3,573).

Most cited papers
#PaperReleasedCitations
1 International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma S. Vincent Rajkumar et al. · The Lancet Oncology Open access 26 Oct 2014 5,031
2 Selective inhibition of BET bromodomains P. Filippakopoulos et al. · Nature Open access 24 Sep 2010 4,363
3 A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature 27 Mar 2005 3,573
4 Artemisinin Resistance in Plasmodium falciparum Malaria Arjen M. Dondorp et al. · New England Journal of Medicine Open access 29 Jul 2009 3,505
5 A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders Róbert Královics, Francesco Passamonti, Andreas S. Buser et al. · New England Journal of Medicine Open access 27 Apr 2005 3,491
All 100 most cited papers, with filters and sorting

Where is Multiple Myeloma Research and Treatments research done?

The largest centres of Multiple Myeloma Research and Treatments research in 2022-now are New York (United States), Beijing (China), Boston (United States) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Hopewell and Lancaster.

Largest cities, 2022-now

  1. 1 New YorkUnited States 229 works
  2. 2 BeijingChina 188 works
  3. 3 BostonUnited States 136 works
  4. 4 HoustonUnited States 111 works
  5. 5 LondonUnited Kingdom 108 works
  6. 6 ShanghaiChina 102 works
  7. 7 ParisFrance 89 works
  8. 8 TokyoJapan 88 works
  9. 9 SeoulSouth Korea 84 works
  10. 10 GuangzhouChina 81 works

Where it is the local speciality

  1. HopewellUS · 22.0 works80×
  2. LancasterUS · 20.2 works31×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Multiple Myeloma Research and Treatments than the world average.

See Multiple Myeloma Research and Treatments on the map

Where is the best place to study Multiple Myeloma Research and Treatments?

Among universities, judged by research, Harvard University, University of Miami and Vrije Universiteit Brussel score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.1%fractional works in this field (log) →share of work in the world top 10% →Vrije Universiteit B…Harvard UniversityUniversity of MiamiUniversity of Würzburg
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 73.921.8%6.4×147 -12.1%
2University of MiamiUnited States 64.318.9%11.4×51 +206.9%
3Vrije Universiteit BrusselBelgium 61.434.2%4.8×10 +35.6%
4University of WürzburgGermany 60.315.0%16.2×37 +29.8%
5Heidelberg UniversityGermany 59.516.3%7.7×43 +8.6%
6National and Kapodistrian University of AthensGreece 59.110.2%15.7×58 +18.4%
7Universidad de NavarraSpain 57.715.9%13.2×26 +60.9%
8Emory UniversityUnited States 55.117.0%7.0×40 +10.4%
9Sichuan UniversityChina 53.017.4%2.4×39 +123.0%
10Universität HamburgGermany 52.914.3%4.9×26 +42.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Multiple Myeloma Research and Treatments, country by country

Is Multiple Myeloma Research and Treatments research growing?

Output in 2022-2025 was 22% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Multiple Myeloma Research and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Multiple Myeloma Research and Treatments as a percentage of every work published that year, 0.033% in 2024.

still counting0.020%0.040%Multiple Myeloma Research and Treatments0.036% in 202519801990200020102020

Fractional works of Multiple Myeloma Research and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Multiple Myeloma Research and Treatments10.6% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Multiple Myeloma Research and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.